Homocysteine and coronary heart disease: Meta-analysis of MTHFR case-control studies, avoiding publication bias

PLoS Medicine

Volumn 9, Issue 2, 2012, Pages

  Clarke, Robert ^a   Bennett, Derrick A ^a   Parish, Sarah ^a   Verhoef, Petra ^b   Dötsch Klerk, Mariska ^b   Lathrop, Mark ^c   Xu, Peng ^c   Nordestgaard, Børge G ^d   Holm, Hilma ^e   Hopewell, Jemma C ^a   Saleheen, Danish ^f,g   Tanaka, Toshihiro ^h   Anand, Sonia S ⁱ   Chambers, John C ^j   Kleber, Marcus E ^k   Ouwehand, Willem H ^f   Yamada, Yoshiji ^l   Elbers, Clara ^m   Peters, Bas ⁿ   Stewart, Alexandre F R ^o   Reilly, Muredach M ^p   Thorand, Barbara ^q   Yusuf, Salim ⁱ   Engert, James C ^r   Assimes, Themistocles L ^s   Kooner, Jaspal ^j   Danesh, John ^f   Watkins, Hugh ^a   Samani, Nilesh J ^t   Collins, Rory ^a   Peto, Richard ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e DECODE GENETICS   (Iceland)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g Center for Non Communicable Diseases   (Pakistan)

^h RIKEN   (Japan)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF FREIBURG   (Germany)

^l MIE UNIVERSITY   (Japan)

^m UTRECHT UNIVERSITY   (Netherlands)

ⁿ UTRECHT UNIVERSITY   (Netherlands)

^o UNIVERSITY OF OTTAWA   (Canada)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q INSTITUTE OF EPIDEMIOLOGY   (Germany)

^r MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^s STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PLACEBO; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; META ANALYSIS; METHYLENE TETRAHYDROFOLATE REDUCTASE GENE; MUTATOR GENE; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; BLOOD; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETICS; RISK FACTOR;

BIAS (EPIDEMIOLOGY); CORONARY DISEASE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84857711683     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001177     Document Type: Article

References (35)

1. McCully KS, (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128.
2. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, et al. (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1-31.
3. Clarke R, Daly L, Robinson K, Naughton E, Cahalane S, et al. (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155.
4. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015-2022.
5. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, et al. (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170: 1622-1631.
6. Wald DS, Morris JK, Wald NJ, (2011) Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PloS One 6: e16473 doi:10.1371/journal.pone.0016473.
7. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
8. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9.
9. Davey Smith G, Ebrahim S, (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22.
10. Wald DS, Law M, Morris JK, (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202.
11. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, et al. (2002) MTHFR 677C-&T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288: 2023-2031.
12. Lewis SJ, Ebrahim S, Davey Smith G, (2005) Meta-analysis of MTHFR 677C-&T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331: 1053.
13. UK Department of Health Scientific Advisory Committee (2006) Folate and disease prevention London HMSO.
14. Wald DS, Wald NJ, Morris JK, Law M, (2006) Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333: 1114-1117.
15. Peden JF, Hopewell JC, Saleheen D, Chambers JC, Hager J, et al. The Coronary Artery Disease (C4D) Genetics Consortium (2011) A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43: 339-344.
16. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
17. Clarke R, Xu P, Bennett D, Lewington S, Zondervan K, et al. (2006) Lymphotoxin-alpha gene (LTA) and risk of myocardial infarction in 6928 cases and 2712 controls in the ISIS case-control study. PloS Genetics 2: e107 doi:10.1371/journal.pgen.0020107.
18. Anand SS, Xie C, Pare G, Montpetit A, Rangarajan S, et al. (2009) INTERHEART Investigators. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: the INTERHEART Genetics Study. Circ Cardiovasc Genet 2: 16-2519.
19. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, et al. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583-612.
20. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L, (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98: 2520-2526.
21. Clarke R, Frost C, Sherliker P, Lewington S, Collins R, for the Homocysteine-Lowering Trialists' Collaboration (2005) Dose-dependent effects of folic acid on plasma homocysteine concentrations. A meta-analysis of the randomised trials. Am J Clin Nutr 82: 806-812.
22. VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the vitamins to prevent stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9: 855-865.
23. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, et al. (2010) Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: randomised placebo controlled trial. BMJ 341: c6273.
24. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, et al. (2011) Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant participants: primary results from the folic acid for vascular outcome reduction in transplantation trial. Circulation 123: 1763-1770.
25. Poole C, Greenland S, (1999) Random-effects meta-analyses are not always conservative. Am J Epidemiol 150: 469-475.
26. Greenland S, (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1-30.
27. Chene G, Thompson SG, (1996) Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 144: 610-621.
28. Cochran W, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
30. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR, (1991) Publication bias in clinical research. Lancet 337: 867-872.
31. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, et al. (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 83: 445-456.
32. Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, et al. (2011) et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378: 584-594.
33. Davey Smith G, Ebrahim S, (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 330: 1076-1079.
34. Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, et al. (2006) Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol 163: 397-403.
35. Bagley PJ, Selhub J, (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95: 13217-13220.